GGrantIndex
← Search

RFA-IP-22-004, Evaluating influenza, SARS-CoV-2, and other respiratory virus vaccine effectiveness in prevention of acute illness in Washington state 2022-2027

$1,400,000U01FY2024IPCDC

Kaiser Foundation Health Plan Of Washington, Seattle WA

Investigators

Linked publications & trials

View original record on NIH RePORTER →